TCL Archive In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available July 1, 1977
TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials September 8, 1978
TCL Archive Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy December 3, 1976
